只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-30 2026-07-30 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn Officer · Chief Scientific Officer | 卖出（S） | 3,847 | US$23.38 | US$89,953.63 | 121,338 | SEC |
| 2026-07-30 2026-07-30 | NRIX Nurix Therapeutics, Inc. | Ring Christine Officer · Chief Legal Officer | 卖出（S） | 3,847 | US$23.38 | US$89,953.63 | 19,912 | SEC |
| 2026-07-30 2026-07-30 | NRIX Nurix Therapeutics, Inc. | van Houte Hans Officer · Chief Financial Officer | 卖出（S） | 2,845 | US$23.38 | US$66,524.07 | 44,927 | SEC |
| 2026-07-02 2026-07-02 | NRIX Nurix Therapeutics, Inc. | Ring Christine Officer · Chief Legal Officer | 卖出（S） | 11,008 | US$23.56 | US$259,366.09 | 13,579 | SEC |
| 2026-06-25 2026-06-25 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn Officer · Chief Scientific Officer | 卖出（S） | 5,394 | US$20.00 | US$107,880.00 | 115,005 | SEC |
| 2026-06-25 2026-06-25 | NRIX Nurix Therapeutics, Inc. | Ring Christine Officer · Chief Legal Officer | 卖出（S） | 28,935 | US$20.06 | US$580,436.10 | 13,579 | SEC |
| 2026-06-02 2026-06-02 | NRIX Nurix Therapeutics, Inc. | Ring Christine Officer · Chief Legal Officer | 卖出（S） | 8,148 | US$16.60 | US$135,256.80 | 13,579 | SEC |
| 2026-05-05 2026-05-05 | NRIX Nurix Therapeutics, Inc. | van Houte Hans Officer · Chief Financial Officer | 卖出（S） | 582 | US$17.18 | US$9,998.76 | 37,592 | SEC |
| 2026-05-05 2026-05-05 | NRIX Nurix Therapeutics, Inc. | van Houte Hans Officer · Chief Financial Officer | 卖出（S） | 13,473 | US$16.58 | US$223,382.34 | 38,174 | SEC |
| 2026-05-04 2026-05-04 | NRIX Nurix Therapeutics, Inc. | Ring Christine Officer · Chief Legal Officer | 卖出（S） | 8,148 | US$16.96 | US$138,190.08 | 18,305 | SEC |
| 2026-05-01 2026-05-01 | NRIX Nurix Therapeutics, Inc. | Ring Christine Officer · Chief Legal Officer | 卖出（S） | 5,394 | US$16.76 | US$90,403.44 | 26,453 | SEC |
| 2026-04-30 2026-04-30 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn Officer · Chief Scientific Officer | 卖出（S） | 3,214 | US$16.65 | US$53,513.10 | 120,399 | SEC |
| 2026-04-30 2026-04-30 | NRIX Nurix Therapeutics, Inc. | Ring Christine Officer · Chief Legal Officer | 卖出（S） | 3,214 | US$16.65 | US$53,513.10 | 31,847 | SEC |
| 2026-04-30 2026-04-30 | NRIX Nurix Therapeutics, Inc. | van Houte Hans Officer · Chief Financial Officer | 卖出（S） | 2,388 | US$16.65 | US$39,760.20 | 51,647 | SEC |
| 2026-04-02 2026-04-02 | NRIX Nurix Therapeutics, Inc. | Ring Christine Officer · Chief Legal Officer | 卖出（S） | 8,148 | US$15.24 | US$124,175.52 | 26,453 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| NRIX | 142,725.0967 | 0 | 215,221.1826 | 66.32% | B, Q, N |